Moderna Stock No-Brainer After FDA Win: Buy or Not?
A recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
A beginner-friendly intro to world stock dividend ETFs, covering basics like yields, diversification, and how to pick your first fund.
23,029 articlesA recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
Rivian vs. Lucid pits two high-profile EV startups against each other. This guide breaks down business models, capita...
CrowdStrike just split stock, turning a high-priced share into four easier-to-access pieces. A lower price can spark ...
Today’s move in redwire stock popped today reflects a developing narrative around space infrastructure and NASA's new...
Celsius shares have fallen more than 50% from their intraday peaks as growth from newly acquired brands accelerates. ...
Red Cat stock crashed today after the company announced a large share offering to raise capital. This piece breaks do...
Rigetti Computing just landed $100 million in CHIPS Act funding. This article breaks down what that means for the com...
The trillion-dollar club is crowded and growing. If micron makes trillion club, it could reshape memory stock bets an...
A SpaceX IPO could ripple across tech and autos. This guide explains how spacex should help rivian through AI compute...
Investors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
A billionaire hedge fund manager shows the power of high-conviction bets in AI. This article breaks down Ackman'...
Alphabet’s latest 13F filing hints at a notable shift in its investment palette. CME Group now sits atop Alphabet’s d...